Skip to main content
Laurence Cooper, MD, Pediatric Hematology & Oncology, Houston, TX, University of Texas M.D. Anderson Cancer Center

LaurenceCooperMD

Pediatric Hematology & Oncology Houston, TX

Professor of Pediatrics, University Tex Houston

Dr. Cooper is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Cooper's full profile

Already have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Pediatric Hematology/Oncology, 1996 - 1999
  • University of Washington
    University of WashingtonResidency, Pediatrics, 1994 - 1996
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2001 - Present
  • UT State Medical License
    UT State Medical License 2017 - 2026
  • TX State Medical License
    TX State Medical License 2006 - 2016
  • WA State Medical License
    WA State Medical License 1999 - 2002
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2013-2014
  • Top Doctors:SE Texas Castle Connolly, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2012-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer  
    Austin D Williams, Amy S Clark, Paul J Zhang, Julia Tchou, Bruce L Levine, Jennifer M Matro, Laurence J Cooper, Alycia So, Lynn M Schuchter, Carl H June, Angela M DeMi..., Clinical Cancer Research

Press Mentions

  • Brain Cancer Biotech Ziopharm Snaps up New CEO from Kuur Therapeutics
    Brain Cancer Biotech Ziopharm Snaps up New CEO from Kuur TherapeuticsAugust 30th, 2021
  • Aldevron Announces Virtual Breakthrough Speaker Series: Dr. Laurence Cooper Is Inaugural Guest
    Aldevron Announces Virtual Breakthrough Speaker Series: Dr. Laurence Cooper Is Inaugural GuestApril 29th, 2021
  • Ziopharm Oncology Announces Election of Robert Postma to Its Board of Directors
    Ziopharm Oncology Announces Election of Robert Postma to Its Board of DirectorsFebruary 5th, 2021
  • Join now to see all

Grant Support

  • Ucb-Derived Cd19-Specific T Cells For Universal Treatment Of B-Cell MalignancyNational Cancer Institute2010–2011
  • T-Cell Therapy For B-Lineage Acute Lymphoblastic LeukemiaNational Cancer Institute2010–2011
  • Enhancing The Efficacy Of Cd19-Specific Cord Blood-Derived T CellsNational Cancer Institute2007–2011
  • Adoptive Immunotherapy After Umbilical Cord Blood TransplantNational Cancer Institute2007–2011
  • Ncounter PREP Station And The Digital AnalyzerNational Center For Research Resources2010
  • Targeting Post-Transplant Minimal Residual CD19+ All With Genetically-National Cancer Institute2006–2010
  • Ucb-Derived Cd19-Specific T Cells For Universal Treatment Of B-Cell MalignancyNational Cancer Institute2007–2008
  • Imaging Infused CD19 Specific T Cells In The TumorNational Cancer Institute2007–2008
  • Cd19-Specific T-Cell Therapy For Follicular LymphomaNational Cancer Institute2003–2004

Hospital Affiliations